AquaBounty Technologies (AQB)
(Delayed Data from NSDQ)
$1.75 USD
-0.05 (-2.78%)
Updated May 31, 2024 04:00 PM ET
After-Market: $1.80 +0.05 (2.86%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
AquaBounty Technologies, Inc. [AQB]
Reports for Purchase
Showing records 21 - 40 ( 59 total )
Company: AquaBounty Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Agriculture & AgTech - On Famine Watch
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: AquaBounty Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Production Escalates to Potential Inflection - Ohio Development Remains on the Horizon
Provider: H.C. Wainwright & Co., Inc.
Analyst: DEDE K
Company: AquaBounty Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: AquaBounty Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: AquaBounty Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Please join us for the inaugural ROTH AgTech Conference scheduled for November 16th
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: AquaBounty Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Value Proposition Reset Presents Attractive Entry Point; Upgrading to Buy and Reinstating Our Old $4.50 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: DEDE K
Company: AquaBounty Technologies, Inc.
Industry: Medical - Biomedical and Genetics
3Q21: 100% Sequential Revenue Growth
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: AquaBounty Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Pioneer, OH Facility Timing on Track
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: AquaBounty Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: AquaBounty Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: AquaBounty Technologies, Inc.
Industry: Medical - Biomedical and Genetics
We initiate coverage of AQB with a Buy rating and $6 price target.
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: AquaBounty Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: AquaBounty Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: AquaBounty Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Risk-Reward Too Heavy for Us; Downgrading to Neutral and Suspending Our Price Target
Provider: H.C. Wainwright & Co., Inc.
Analyst: DEDE K
Company: AquaBounty Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: AquaBounty Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Sept Tested Operating Metrics, but Sales Missed Our Premature Timeline; Kentucky Buildout Resets Valuation; Reit Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: DEDE K
Company: AquaBounty Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Commercial Harvest Raises Investment Standing; Reit Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: DEDE K
Company: AquaBounty Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Institutional Outreach Spotlights Clever Solutions Tailored to Address Global Problems; Reit Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: DEDE K
Company: AquaBounty Technologies, Inc.
Industry: Medical - Biomedical and Genetics
White House Pushes for Increased Domestic Fish Production Ultimately Targeting U.S. Self-Sufficiency; Reit Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: DEDE K
Company: AquaBounty Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Stocking Tanks and Cash Coffers; Reit Buy on Lower $3.50 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: DEDE K